do glp 1 change your taste buds Frontiers Glucagon-Like Peptide 1 and Taste

Grant Funding Now Available in Illinois for Qualified Cities and Schools

A new study suggests that an older GLP-1 drug may help protect the brains of people with early Alzheimers disease, though more research is needed.

United by a shared mission to enhance obesity care, MYOS focuses on advancing clinical practice, raising awareness, and sharing expertise to improve the lives of people affected by obesity.

As patents for Semaglutide begin to expire, we are moving from a period of high-cost exclusivity to a new era of mass accessibility

At the same time, payer policies often require discontinuation of GLP-1 therapy when a patients BMI drops below a set threshold, inadvertently triggering a frustrating cycle of weight loss and regainthe so-called yo-yo effect. This not only impacts ongoing adherence and persistence but also undermines the long-term cost-effectiveness of these therapies for healthcare systems

Kentucky residents have three paths to GLP-1 weight-loss therapy in 2026: brand-name FDA-approved medication (Wegovy, Zepbound) at retail or Lilly Direct, in-person clinical care through systems like UK HealthCare Turfland, and cash-pay compounded telehealth